Cordio Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Later Stage VC
- Investors
-
10
Cordio General Information
Description
Developer of speech processing platform designed for monitoring health conditions through the voice of patients. The company's platform permits near real-time monitoring and early detection of condition deterioration and is based on true speech signal processing technology, specific to each patient and augmented with machine learning capabilities, enabling physicians and patients to identify and mitigate condition worsening by helping physicians to prevent patient deterioration and hospitalization while keeping the patient's wellbeing at the core.
Contact Information
Website
www.cordio-med.comCorporate Office
- 6 Yehonatan Netanyahu Street
- Or Yehuda 6037604
- Israel
Corporate Office
- 6 Yehonatan Netanyahu Street
- Or Yehuda 6037604
- Israel
Cordio Timeline
Cordio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Jan-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 27-Jun-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 12-Jan-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 26-Oct-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 01-Sep-2021 | Completed | Generating Revenue | |||
| 3. Equity Crowdfunding | 22-Jul-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 13-Jul-2021 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jan-2015 | Completed | Generating Revenue |
Cordio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred C | ||||||||
| Preferred B | ||||||||
| Preferred A1 | 240,000 | $11.69 | $11.69 | 1x | $11.69 | 13.15% | ||
| Preferred A | 745,423 | $4.47 | $4.47 | 1x | $4.47 | 5.69% |
Cordio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cordio Patents
Cordio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240265937-A1 | Identifying optimal articulatory event-types for computer analysis of speech | Pending | 05-Feb-2023 | ||
| US-20220165295-A1 | Detecting impaired physiological function by speech analysis | Pending | 23-Nov-2020 | ||
| AU-2021384028-A1 | Detecting impaired physiological function from exhaled gas concentrations and spectral envelope extracted from speech analysis | Pending | 23-Nov-2020 | ||
| CA-3200531-A1 | Detecting impaired physiological function from exhaled gas concentrations and spectral envelope extracted from speech analysis | Pending | 23-Nov-2020 | ||
| EP-4000529-A1 | Detecting impaired physiological function by speech analysis | Pending | 23-Nov-2020 | G10L25/66 |
Cordio Executive Team (9)
| Name | Title | Board Seat |
|---|---|---|
| Tamir Tal | Chief Executive Officer | |
| Ilan Shallom | Chief Technology Officer | |
| Aviv Lotan | Co-Founder | |
| Chaim Lotan MD | Co-Founder, Chief Medical Officer & Board Member | |
| Lior Shahory | General Partner & Board Member |
Cordio Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Chaim Lotan MD | Cordio | Co-Founder, Chief Medical Officer & Board Member | |
| David Lifschitz | Self | Board Member | |
| Eyal Lifschitz | Peregrine Ventures | Chairman | |
| Lior Shahory | Self | General Partner & Board Member | |
| Sandra Morgan | Self | Board Member & Executive Advisor |
Cordio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cordio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hadasit | Venture Capital | Minority | ||
| Iron Nation | Venture Capital | Minority | ||
| Ceros Capital Markets | Venture Capital | Minority | ||
| Ceros Financial Services | Corporation | Minority | ||
| OurCrowd | Venture Capital | Minority |
Cordio FAQs
-
When was Cordio founded?
Cordio was founded in 2013.
-
Who is the founder of Cordio?
Shelly Lotan, Aviv Lotan, Chaim Lotan MD, Ze'ev Schlik, and Sigal Kremer-Tal MD are the founders of Cordio.
-
Who is the CEO of Cordio?
Tamir Tal is the CEO of Cordio.
-
Where is Cordio headquartered?
Cordio is headquartered in Or Yehuda, Israel.
-
What is the size of Cordio?
Cordio has 32 total employees.
-
What industry is Cordio in?
Cordio’s primary industry is Other Healthcare Technology Systems.
-
Is Cordio a private or public company?
Cordio is a Private company.
-
What is Cordio’s current revenue?
The current revenue for Cordio is .
-
How much funding has Cordio raised over time?
Cordio has raised $26.7M.
-
Who are Cordio’s investors?
Hadasit, Iron Nation, Ceros Capital Markets, Ceros Financial Services, and OurCrowd are 5 of 10 investors who have invested in Cordio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
